Table 1.

Overview of patients included in this study and their evaluated capacity to respond ( +) or not respond (−) to supraphysiological loading with the release of osteoclast-stimulating soluble factors.

Patient ID	Age	Gender	Mesenchymal stromal cells	Osteoprogenitor	Pre-osteoblasts	Monocytes	Pre-osteoclasts
001H	44	Female	+	+	+	+	−
002H	53	Male	+	+	+	+	−
004H	54	Female	+	+	+	+	−
005H	61	Male	+	+	+	+	−
013H	51	Female	+	−	−	+	−
014H	66	Male	+	−	−	+	−